NextPlat Corp (NASDAQ:NXPL – Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 133,800 shares, a drop of 36.0% from the January 15th total of 209,100 shares. Approximately 1.0% of the shares of the stock are sold short. Based on an average daily volume of 376,600 shares, the short-interest ratio is currently 0.4 days.
NextPlat Trading Up 2.4 %
NXPL opened at $1.06 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.04 and a current ratio of 3.70. The firm’s fifty day moving average is $1.12 and its 200 day moving average is $1.13. NextPlat has a fifty-two week low of $0.71 and a fifty-two week high of $2.68.
Hedge Funds Weigh In On NextPlat
Several large investors have recently made changes to their positions in NXPL. Renaissance Technologies LLC purchased a new stake in shares of NextPlat during the fourth quarter worth about $30,000. Omnia Family Wealth LLC purchased a new stake in NextPlat during the 3rd quarter valued at approximately $132,000. Finally, Geode Capital Management LLC raised its position in shares of NextPlat by 54.6% during the fourth quarter. Geode Capital Management LLC now owns 165,459 shares of the company’s stock valued at $179,000 after buying an additional 58,402 shares during the last quarter. 1.30% of the stock is currently owned by hedge funds and other institutional investors.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Featured Stories
- Five stocks we like better than NextPlat
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Which Wall Street Analysts are the Most Accurate?
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- How to Use Stock Screeners to Find Stocks
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.